Literature DB >> 10679107

Role for IgE in airway secretions: IgE immune complexes are more potent inducers than antigen alone of airway inflammation in a murine model.

R I Zuberi1, J R Apgar, S S Chen, F T Liu.   

Abstract

IgE is present in airway secretions from human patients with allergic rhinitis and bronchial asthma. However, the contribution of IgE present locally to the overall airway inflammation is not well understood. We hypothesize that Ag-specific IgE can capture airborne Ags and form immune complexes. These immune complexes may function as potent inducers of immune responses in the lung, contributing to the perpetuation of airway inflammation. BALB/c mice were first sensitized with OVA in alum systemically and then challenged with nebulized OVA. Bronchoalveolar lavage (BAL) fluid from these mice contained significant amounts of IgE, of which >50% was Ag specific. The IgE levels in airway secretions remained elevated for more than 15 days after the termination of Ag exposure. Significant amounts of IgE-OVA immune complexes were detected in BAL fluid from the OVA-challenged mice. For comparison of IgE immune complexes vs Ag alone, we treated OVA-immunized mice with intranasal administration of trinitrophenyl-OVA or trinitrophenyl-OVA-anti-DNP IgE. Those treated with the immune complexes showed significantly higher levels of IL-4 and more pronounced eosinophilia in BAL fluid than did those receiving the Ag alone. The IgE immune complexes did not augment the inflammatory response in high affinity IgE receptor (FcepsilonRI)-deficient mice. We conclude that IgE present in the airways can capture the Ag and that the immune complexes thus formed may augment allergic airway response in an FcepsilonRI-dependent manner. Thus, IgE present in airway secretions may facilitate Ag-mediated allergic airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679107     DOI: 10.4049/jimmunol.164.5.2667

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Peptides       Date:  2010-10-13       Impact factor: 3.750

2.  Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse model.

Authors:  Felix Nau; Justin Miller; Jordy Saravia; Terry Ahlert; Bangning Yu; Kyle I Happel; Stephania A Cormier; Charles D Nichols
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-15       Impact factor: 5.464

3.  IgE immune complexes stimulate an increase in lung mast cell progenitors in a mouse model of allergic airway inflammation.

Authors:  Joakim S Dahlin; Martin A Ivarsson; Birgitta Heyman; Jenny Hallgren
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

4.  Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma.

Authors:  Riaz I Zuberi; Daniel K Hsu; Omer Kalayci; Huan-Yuan Chen; Holly K Sheldon; Lan Yu; John R Apgar; Toshiaki Kawakami; Craig M Lilly; Fu-Tong Liu
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

5.  Similar response in male and female B10.RIII mice in a murine model of allergic airway inflammation.

Authors:  Victor Matheu; Ysamar Barrios; Maria-Rosa Arnau; Vaidrius Navikas; Shohreh Issazadeh-Navikas
Journal:  Inflamm Res       Date:  2009-09-25       Impact factor: 4.575

6.  Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10.

Authors:  Lucila G G Pacífico; Fábio A V Marinho; Cristina T Fonseca; Michele M Barsante; Vanessa Pinho; Policarpo A Sales-Junior; Luciana S Cardoso; Maria Ilma Araújo; Edgar M Carvalho; Geovanni D Cassali; Mauro M Teixeira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

7.  Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.

Authors:  A G Jember; R Zuberi; F T Liu; M Croft
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

8.  Impact on allergic immune response after treatment with vitamin A.

Authors:  Victor Matheu; Karin Berggård; Yvelise Barrios; Ysamar Barrios; Maria-Rosa Arnau; Jose M Zubeldia; Maria L Baeza; Ove Back; Shohreh Issazadeh-Navikas
Journal:  Nutr Metab (Lond)       Date:  2009-10-23       Impact factor: 4.169

9.  Differential regulation of inflammation and immunity in mild and severe experimental asthma.

Authors:  Seil Sagar; Kim A T Verheijden; Niki A Georgiou; Johan Garssen; Aletta D Kraneveld; Arjan P Vos; Gert Folkerts
Journal:  Mediators Inflamm       Date:  2013-05-27       Impact factor: 4.711

10.  Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.

Authors:  Victor Matheu; Alexandra Treschow; Ingrid Teige; Vaidrius Navikas; Shohreh Issazadeh-Navikas
Journal:  Respir Res       Date:  2005-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.